Translator Disclaimer
1 June 2005 AVIAN TITER DEVELOPMENT AGAINST WEST NILE VIRUS AFTER EXTRALABEL USE OF AN EQUINE VACCINE
Author Affiliations +
Abstract

West Nile virus affects many animals, but the highest prevalence of morbidity and mortality is observed in birds, horses, and humans. The purpose of this study was to determine a protocol in birds of prey and corvids, using a vaccine developed for horses. The birds were assigned to five groups. Groups 1–4 received 0.25 ml, 0.5 ml, 0.75 ml, and 1.0 ml, respectively, and group 5 served as a control group. The greatest percentage of seroconversion (58.3%) was observed in the vaccine group that received a dose of 1.0 ml administered thrice, 3 wk apart. This report demonstrates that a vaccine developed for equines against West Nile virus can be administered to birds.

Sharmie Johnson "AVIAN TITER DEVELOPMENT AGAINST WEST NILE VIRUS AFTER EXTRALABEL USE OF AN EQUINE VACCINE," Journal of Zoo and Wildlife Medicine 36(2), 257-264, (1 June 2005). https://doi.org/10.1638/03-094.1
Received: 9 December 2003; Published: 1 June 2005
JOURNAL ARTICLE
8 PAGES


SHARE
ARTICLE IMPACT
RIGHTS & PERMISSIONS
Get copyright permission
Back to Top